Publicaciones (326) Publicaciones de MARIO FERNÁNDEZ RUIZ

2024

  1. BK polyomavirus-associated nephropathy, graft inflammation, and immunosuppression: Shedding light on the conundrum

    Transplant Infectious Disease

  2. Bacteremia due to Leuconostoc species: A 13-year single-center case series

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 3, pp. 149-151

  3. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation

  4. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  5. Pharmacological management of invasive mold infections in solid organ transplant recipients

    Expert Opinion on Pharmacotherapy

  6. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

  7. Reduction of Instrumentation-Related Spine Surgical Site Infections After Optimization of Surgical Techniques. A Single Center Retrospective Analysis

    Global Spine Journal, Vol. 14, Núm. 2, pp. 438-446

  8. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

    Transplant Infectious Disease, Vol. 26, Núm. 1

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  3. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  4. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

  5. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  6. Comprehensive analysis of current epidemiology, clinical features and Prognostic Factors of puerperal endometritis: A retrospective cohort analysis

    European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 18

  7. Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis

    Transplant International

  8. Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?

    Transplant International, Vol. 36

  9. Dynamics of Human Anelloviruses in Plasma and Clinical Outcomes Following Kidney Transplantation

    Transplantation, Vol. 107, Núm. 2, pp. 511-520

  10. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  11. Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial

    BMJ open, Vol. 13, Núm. 9, pp. e072121

  12. Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients

    Transplantation Reviews